About Qualitest Pharmaceuticals
Qualitest Pharmaceuticals is a Healthcare company based in Huntsville (United States) founded in 1983, and was acquired by Endo International in September 2010. Provider of arbitration, mediation, and legal consulting for international commercial disputes. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Qualitest Pharmaceuticals was established in 1983 in Huntsville, United States, within the legal services sector. Arbitration, mediation, and consulting are offered to handle international commercial disputes. Resolutions are achieved through structured processes, inter-party communication is supported, and compliance with global laws is verified. Decision frameworks and preventive measures against disputes are supplied. Operations focus on guiding businesses through cross-border legal complexities in various markets.
- Headquarters Huntsville, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website qualitestrx.com
- Social LinkedIn Facebook
- Acquired by Endo International (Sep 2010)
- Investors
- Acquired byEndo International
(Sep 2010)
Investors in Qualitest Pharmaceuticals
Qualitest Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Endo International.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global pharmaceutical company manufacturing branded, generic formulations, and OTC medicines | 1997 | endo.com | Malvern, United States |
Investor details for Qualitest Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Qualitest Pharmaceuticals
2 dated milestones of Qualitest Pharmaceuticals across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Qualitest Pharmaceuticals is founded.
- Exit Acquired by Endo International.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Qualitest Pharmaceuticals (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Qualitest Pharmaceuticals
Qualitest Pharmaceuticals was founded in 1983.
Qualitest Pharmaceuticals is headquartered in Huntsville, United States. It is registered at Huntsville, Alabama, United States.
Qualitest Pharmaceuticals was established in 1983 in Huntsville, United States, within the legal services sector. Arbitration, mediation, and consulting are offered to handle international commercial disputes. Resolutions are achieved through structured processes, inter-party communication is supported, and compliance with global laws is verified. Decision frameworks and preventive measures against disputes are supplied. Operations focus on guiding businesses through cross-border legal complexities in various markets.
Qualitest Pharmaceuticals has 1 investor. Key investors include Endo International.
Yes. Qualitest Pharmaceuticals was acquired by Endo International in September 2010.